CDC: Invasive Cancer Incidence Down from 2010

Share this content:
CDC: Invasive Cancer Incidence Down from 2010
CDC: Invasive Cancer Incidence Down from 2010

(HealthDay News) — Cancer incidence declined from 2009 to 2010, according to a report published in the March 28 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

S. Jane Henley, MSPH, from the CDC in Atlanta, and colleagues analyzed incidence data from U.S. Cancer Statistics for 2010 in order to assess progress towards reaching Healthy People 2020 targets.

The researchers found that, in 2010, 1,456,496 invasive cancers were reported to cancer registries in the United States (excluding Arkansas and Minnesota), yielding an annual incidence rate of 446 cases per 100,000 persons, compared with 459 in 2009.

RELATED: Progress in the 'War on Cancer'

Men had higher cancer incidence rates (503) compared with women (405). Incidence rates were highest among blacks (455), and were driven by higher rates of prostate cancer and female breast cancer.

Cancer incidence ranged by state from 380 to 511 per 100,000 persons. Fifteen states achieved 2020 targets for reduced incidence of colorectal cancer and 24 reached targets for reduced incidence of cervical cancer.

"Many factors, including tobacco use, obesity, insufficient physical activity, and human papillomavirus infection, contribute to the risk for developing cancer, and differences in cancer incidence indicate differences in the prevalence of these risk factors," the researchers wrote.


  1. Henley SJ, Singh S, King J, et al. Invasive Cancer Incidence — United States, 2010. MMWR. 2014; 63(12);253-259.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs